The company is boosting investment in its product development portfolio, specifically targeting its digital health ecosystem and software solutions.
Filing excerpt
Research and development expenses for the three months ended December 31, 2025 were $88.8 million, an increase of 10% compared to the same period of the prior year.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10qplatformStrategyGet every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e1a149e6-fcc4-4d72-a04b-9b0c6f35d445 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.
{
"signal_id": "e1a149e6-fcc4-4d72-a04b-9b0c6f35d445",
"signal_type": "sec-10q",
"signal_subtype": "platformStrategy",
"detected_at": "2026-02-03T08:37:20.04+00:00",
"company": {
"name": "ResMed",
"domain": "resmed.com"
},
"data": {
"detail": "The company is boosting investment in its product development portfolio, specifically targeting its digital health ecosystem and software solutions. This budget allocation indicates a strategic priority to build out its technology platform, creating opportunities for vendors in cloud services, data analytics, IoT, and cybersecurity for connected medical devices.",
"metrics": {
"pct": 0.1,
"timeframe": "current_quarter",
"pct_context": "YoY increase in R&D spending",
"dollar_context": "Quarterly research and development expenses",
"dollar_millions": 88.8
},
"summary": "ResMed increased R&D spending by 10% to $88.8M to fund its digital health ecosystem.",
"excerpts": "Research and development expenses for the three months ended December 31, 2025 were $88.8 million, an increase of 10% compared to the same period of the prior year.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000007/rmd-20251231.htm",
"filing_date": "2026-01-29",
"filing_year": 2026,
"fiscal_year": 0,
"sales_relevance": "Platform tools needed",
"signal_category": "strategic",
"technologies_mentioned": [
"digital health",
"software"
]
}
}
curl https://signals.autobound.ai/v1/signals/e1a149e6-fcc4-4d72-a04b-9b0c6f35d445 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"resmed.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.